DadFinStart your free week
DadFin › Stocks › Healthcare › ALGN

Align Technology, Inc. (ALGN) stock score

Healthcare · Medical Instruments & Supplies · United States

$142.71 ▲ +1.19% today

50.0
Dad Score, out of 100
middling

Align Technology, Inc. (ALGN) is a Medical Instruments & Supplies company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 50.0 out of 100 on the Dad Score, a middling reading that places the business ahead of 50% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #417 of 974. Its strongest axes are valuation, quality and risk; its weakest are growth and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Strong
Quality
Strong
Growth
Below average
Price action
Below average
Risk
Strong
Conviction
Weak
Liquidity
Strong
Macro
Average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)25.0×
P/E (forward)11.5×
Dividend yield0.00%
Return on capital13.6%
Operating margin18.2%
Revenue growth (YoY)+0.9%
FCF yield5.4%
Net debt / EBITDA-1.06×
Piotroski F-Score6 / 9
52-week change+9.3%
Market cap$10.2B
Next earningsOct 28, 2026

What subscribers see on ALGN

Start your free weekSubscriber? Open the full research →

Medical Instruments & Supplies peers

StockCompanyDad ScoreBandMarket cap
ISRGIntuitive Surgical, Inc.87.0strong$140.4B
BDXBecton, Dickinson and Company69.8middling$48.2B
MDLNMedline Inc.98.2strong$47.9B
ALCAlcon Inc.64.6middling$30.8B
RMDResMed Inc.94.3strong$30.8B
WSTWest Pharmaceutical Services, Inc.90.1strong$25.7B
SOLVSolventum Corporation71.9good$15.0B
BAXBaxter International Inc.40.5middling$12.1B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.